NIGMS Director’s Update – June 10
Includes a Live Event on 06/10/2020 at 3:00 PM (EDT)
Join Jon Lorsch, PhD, Director of the National Institute of General Medical Sciences (NIGMS), for an update on key NIGMS issues for the extramural research and research training community. Dr. Lorsch will address:
- NIGMS support of faculty and trainees during the COVID-19 pandemic
- Progress of MIRA (R35) awards for early-career and established investigators
- Update on revised NIGMS T32 training programs
- Support for regional facilities and lab safety in training environments
Dr. Lorsch welcomes discussion during a question and answer period to follow the presentation.
You may also submit questions ahead of time to Amanda Field, PhD, AAMC Senior Science Policy Specialist, at email@example.com.
The AAMC looks forward to providing this platform for interaction with the GREAT and GRAND communities on these and future topics. Please send topic suggestions to Amanda Field (above).
Jon R. Lorsch, PhD
Director of the NIH National Institute of General Medical Sciences (NIGMS)
Jon Lorsch became the director of NIGMS in August 2013. In this position, Lorsch oversees the Institute's $2.9 billion budget, which supports basic research that increases understanding of biological processes and lays the foundation for advances in disease diagnosis, treatment, and prevention. NIGMS supports more than 3,000 investigators and 5,000 research grants–around 11 percent of the total number of research grants funded by NIH as a whole. Additionally, NIGMS supports around 26 percent of the NRSA trainees who receive assistance from NIH.